Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
Before starting Spravato, ask exactly how your clinic handles the required observation period, blood pressure checks, discharge decision, and ride home. Spravato is the brand name for esketamine, a nasal spray that the U.S. Food and Drug Administration has approved for treatment-resistant depression. It is available only through a Risk Evaluation and Mitigation Strategy, or REMS, program because sedation, dissociation, respiratory depression, and misuse are important safety concerns.
Your questions should help you understand what will happen on treatment day and who will respond if you do not feel ready to leave after the minimum monitoring period. This is educational information, not medical advice. Discuss your health history and treatment decision with the licensed clinician overseeing your care.
Quick Answer
Ask whether the clinic and prescriber are certified in the Spravato REMS program, how they monitor you for at least two hours after each dose, and what would extend that observation period. Also confirm how you will get home, when you can resume driving, and whom to contact if concerning symptoms occur after you leave. The answers should be specific to the clinic's written process and your own medical history.
Spravato REMS Monitoring at a Glance
Ask how the clinic meets Spravato REMS requirements
The Spravato REMS program requires treatment in a certified healthcare setting, with the medicine administered under direct observation and patients monitored for at least two hours. A certified pharmacy dispenses Spravato only to certified treatment settings, not for patients to take home.
Bring these questions to your consultation:
- Are the prescriber, treatment setting, and pharmacy enrolled and certified in the Spravato REMS program?
- Who will monitor me during the observation period, and how often will they check on me?
- Where will I wait after treatment, and what support is available if I feel distressed, very sleepy, or disoriented?
- What findings would mean I need monitoring longer than two hours or a higher level of care?
- How do you document that I am safe to leave?
These questions complement broader questions to ask before ketamine therapy, especially if you are comparing several treatment options.
Ask about blood pressure, sedation, and dissociation
Spravato can temporarily raise blood pressure, and the FDA-approved prescribing information calls for blood pressure assessment before treatment and reassessment at about 40 minutes after dosing. The same label requires observation for sedation and dissociation, which can include feeling detached from yourself, your thoughts, or your surroundings.
Ask your clinician: “What is my baseline blood pressure today?” “What symptoms should I report immediately?” and “How would my other medicines, alcohol use, sleep problems, or health conditions affect the monitoring plan?” Your clinician may need to assess factors that can increase risk, including cardiovascular history or medicines that affect alertness or blood pressure.
According to the FDA-approved Spravato prescribing information, patients must not drive or operate machinery until the next day after a restful sleep. Confirm your transportation plan before every treatment visit, even if you felt well after a prior session.
Compare your options before deciding
See route, setting, cost, and safety differences before your next provider conversation.
Compare treatment optionsPlan transportation before your appointment
Do not plan to drive yourself home after Spravato treatment. Ask whether the clinic has rules about a family member, friend, rideshare, or other transportation, and what happens if your ride is delayed. The FDA labeling says to avoid driving or operating machinery until the next day after a restful sleep.
Ask what treatment day will feel like from check-in to discharge
A reliable clinic should be able to describe the day in plain language, including check-in, pre-dose screening, administration, observation, reassessment, and discharge. The goal is not to predict your exact experience. It is to make sure you know what support and decisions are built into the visit.
- What should I eat, drink, or avoid before my appointment, based on the prescribing information and my clinician's instructions?
- Can a family member wait with me or receive discharge instructions?
- Who decides whether I can leave, and can I call someone from the clinic if I have concerns later that day?
- How will you coordinate with my regular psychiatrist, therapist, or primary care clinician if I have one?
If you are preparing for a psychiatric evaluation, review these questions to ask a psychiatrist about ketamine therapy. You can also use questions to ask about ketamine treatment consent form to clarify risks, alternatives, and the clinic's responsibilities before signing.
Bring this REMS monitoring checklist
- Write down your current medicines, supplements, allergies, and relevant health conditions for the prescribing clinician.
- Arrange a ride home before booking the appointment and confirm the clinic's transportation policy.
- Ask for the clinic's after-hours contact process and what symptoms warrant urgent help.
- Ask how the clinic communicates with your existing mental health and primary care clinicians, if applicable.
Use REMS monitoring questions to judge whether the setting fits you
REMS enrollment is a required safety framework, not a guarantee that every clinic will feel equally organized or supportive. A good fit is a setting that explains its process without minimizing uncertainty, welcomes your questions, checks relevant medical history, and gives clear instructions for treatment day and follow-up.
Spravato is different from off-label ketamine treatment. Ketamine is prescribed off-label for depression and most mental health uses, while esketamine is FDA-approved for treatment-resistant depression and is subject to its own REMS program. If you are still determining whether any ketamine-based treatment fits your situation, start with these ketamine treatment eligibility questions and questions to ask about ketamine treatment goals at a first consultation.
Choose a provider with clear safety processes
Use our provider guide to compare credentials, screening practices, continuity of care, costs, and the questions that matter before you commit to treatment.
Frequently Asked Questions
Yes. The FDA-approved prescribing information requires monitoring for at least two hours after Spravato administration. Your clinician may recommend longer observation if your condition or symptoms warrant it.
No. Under the Spravato REMS program, Spravato is administered under direct observation in a certified healthcare setting and is not dispensed directly to patients for home use.
Ask your clinic for specific written instructions before treatment, including its after-hours contact route and when to seek urgent medical help. Report concerning symptoms promptly rather than trying to manage them alone.
Share
Related Reading
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.